Alikem Limited (AKE.CA) Fundamental Analysis & Valuation

TSX:AKE • AU0000193666

Current stock price

8.86 CAD
-0.05 (-0.56%)
Last:

This AKE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. AKE.CA Profitability Analysis

1.1 Basic Checks

  • AKE had positive earnings in the past year.
  • In the past year AKE had a positive cash flow from operations.
  • In multiple years AKE reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: AKE reported negative operating cash flow in multiple years.
AKE.CA Yearly Net Income VS EBIT VS OCF VS FCFAKE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

1.2 Ratios

  • AKE has a Return On Assets of 8.47%. This is amongst the best in the industry. AKE outperforms 94.81% of its industry peers.
  • AKE has a better Return On Equity (12.98%) than 95.04% of its industry peers.
  • AKE's Return On Invested Capital of 12.94% is amongst the best of the industry. AKE outperforms 97.76% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AKE is significantly below the industry average of 13.35%.
  • The last Return On Invested Capital (12.94%) for AKE is above the 3 year average (6.50%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.47%
ROE 12.98%
ROIC 12.94%
ROA(3y)3.62%
ROA(5y)2.24%
ROE(3y)4.75%
ROE(5y)2.86%
ROIC(3y)6.5%
ROIC(5y)N/A
AKE.CA Yearly ROA, ROE, ROICAKE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

  • AKE's Profit Margin of 36.57% is amongst the best of the industry. AKE outperforms 98.58% of its industry peers.
  • In the last couple of years the Profit Margin of AKE has grown nicely.
  • Looking at the Operating Margin, with a value of 72.27%, AKE belongs to the top of the industry, outperforming 99.76% of the companies in the same industry.
  • AKE has a Gross Margin of 84.30%. This is amongst the best in the industry. AKE outperforms 99.29% of its industry peers.
  • AKE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 72.27%
PM (TTM) 36.57%
GM 84.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.05%
GM growth 3Y136.76%
GM growth 5Y26.6%
AKE.CA Yearly Profit, Operating, Gross MarginsAKE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. AKE.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKE is still creating some value.
  • The number of shares outstanding for AKE remains at a similar level compared to 1 year ago.
  • AKE has a better debt/assets ratio than last year.
AKE.CA Yearly Shares OutstandingAKE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
AKE.CA Yearly Total Debt VS Total AssetsAKE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

  • AKE has an Altman-Z score of 2.56. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AKE has a Altman-Z score (2.56) which is in line with its industry peers.
  • AKE has a debt to FCF ratio of 1.28. This is a very positive value and a sign of high solvency as it would only need 1.28 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.28, AKE belongs to the top of the industry, outperforming 95.28% of the companies in the same industry.
  • AKE has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • AKE has a worse Debt to Equity ratio (0.08) than 67.06% of its industry peers.
  • Although AKE's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.28
Altman-Z 2.56
ROIC/WACC1.48
WACC8.75%
AKE.CA Yearly LT Debt VS Equity VS FCFAKE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

  • AKE has a Current Ratio of 2.52. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
  • AKE's Current ratio of 2.52 is in line compared to the rest of the industry. AKE outperforms 50.06% of its industry peers.
  • A Quick Ratio of 2.23 indicates that AKE has no problem at all paying its short term obligations.
  • The Quick ratio of AKE (2.23) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.23
AKE.CA Yearly Current Assets VS Current LiabilitesAKE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AKE.CA Growth Analysis

3.1 Past

  • AKE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.94%, which is quite impressive.
  • The Earnings Per Share has been growing by 142.97% on average over the past years. This is a very strong growth
  • The Revenue has grown by 62.19% in the past year. This is a very strong growth!
  • The Revenue has been growing by 133.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5Y142.97%
EPS Q2Q%-9.87%
Revenue 1Y (TTM)62.19%
Revenue growth 3Y150.24%
Revenue growth 5Y133.56%
Sales Q2Q%15.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 0.91% on average over the next years.
  • The Revenue is expected to grow by 8.16% on average over the next years. This is quite good.
EPS Next Y-17.91%
EPS Next 2Y-1.44%
EPS Next 3Y12.46%
EPS Next 5Y0.91%
Revenue Next Year-5.44%
Revenue Next 2Y4.69%
Revenue Next 3Y11.08%
Revenue Next 5Y8.16%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.CA Yearly Revenue VS EstimatesAKE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AKE.CA Yearly EPS VS EstimatesAKE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. AKE.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.53, which indicates a very decent valuation of AKE.
  • AKE's Price/Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 94.57% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of AKE to the average of the S&P500 Index (26.77), we can say AKE is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 11.57, the valuation of AKE can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, AKE is valued cheaper than 92.21% of the companies in the same industry.
  • AKE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.53
Fwd PE 11.57
AKE.CA Price Earnings VS Forward Price EarningsAKE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 95.16% of the companies in the same industry are more expensive than AKE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.7
EV/EBITDA N/A
AKE.CA Per share dataAKE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The decent profitability rating of AKE may justify a higher PE ratio.
  • A more expensive valuation may be justified as AKE's earnings are expected to grow with 12.46% in the coming years.
PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2Y-1.44%
EPS Next 3Y12.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AKE.CA Dividend Analysis

5.1 Amount

  • AKE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AKE.CA Fundamentals: All Metrics, Ratios and Statistics

Alikem Limited

TSX:AKE (12/21/2023, 7:00:00 PM)

8.86

-0.05 (-0.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)01-04
Inst Owners21.93%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.68B
Revenue(TTM)1.21B
Net Income(TTM)441.71M
Analysts78.1
Price Target12.46 (40.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.36%
PT rev (3m)-18.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-25.58%
EPS NY rev (3m)-39.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-19.99%
Revenue NY rev (3m)-28.73%
Valuation
Industry RankSector Rank
PE 9.53
Fwd PE 11.57
P/S 3.55
P/FCF 16.7
P/OCF 5.42
P/B 1.26
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)0.93
EY10.5%
EPS(NY)0.77
Fwd EY8.64%
FCF(TTM)0.53
FCFY5.99%
OCF(TTM)1.63
OCFY18.45%
SpS2.5
BVpS7.03
TBVpS5.96
PEG (NY)N/A
PEG (5Y)0.07
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 8.47%
ROE 12.98%
ROCE 18.29%
ROIC 12.94%
ROICexc 15.63%
ROICexgc 18.01%
OM 72.27%
PM (TTM) 36.57%
GM 84.3%
FCFM 21.25%
ROA(3y)3.62%
ROA(5y)2.24%
ROE(3y)4.75%
ROE(5y)2.86%
ROIC(3y)6.5%
ROIC(5y)N/A
ROICexc(3y)7.8%
ROICexc(5y)N/A
ROICexgc(3y)9.02%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.05%
GM growth 3Y136.76%
GM growth 5Y26.6%
F-Score8
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 44.23%
Interest Coverage -62.06
Cash Conversion N/A
Profit Quality 58.11%
Current Ratio 2.52
Quick Ratio 2.23
Altman-Z 2.56
F-Score8
WACC8.75%
ROIC/WACC1.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)64.83%
Cap/Sales(5y)84.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5Y142.97%
EPS Q2Q%-9.87%
EPS Next Y-17.91%
EPS Next 2Y-1.44%
EPS Next 3Y12.46%
EPS Next 5Y0.91%
Revenue 1Y (TTM)62.19%
Revenue growth 3Y150.24%
Revenue growth 5Y133.56%
Sales Q2Q%15.2%
Revenue Next Year-5.44%
Revenue Next 2Y4.69%
Revenue Next 3Y11.08%
Revenue Next 5Y8.16%
EBIT growth 1Y87.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-19.97%
EBIT Next 3Y10.39%
EBIT Next 5Y7.54%
FCF growth 1Y42.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.1%
OCF growth 3YN/A
OCF growth 5YN/A

Alikem Limited / AKE.CA Fundamental Analysis FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 6 / 10 to AKE.CA.


Can you provide the valuation status for Alikem Limited?

ChartMill assigns a valuation rating of 6 / 10 to Alikem Limited (AKE.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for Alikem Limited?

Alikem Limited (AKE.CA) has a profitability rating of 7 / 10.


What are the PE and PB ratios of Alikem Limited (AKE.CA) stock?

The Price/Earnings (PE) ratio for Alikem Limited (AKE.CA) is 9.53 and the Price/Book (PB) ratio is 1.26.


Can you provide the financial health for AKE stock?

The financial health rating of Alikem Limited (AKE.CA) is 7 / 10.